$43.090
-0.526 (-1.22%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
URGN Prediction & Forecast by Similar Chart Analysis
Alphio's URGN stock price prediction model matches the current Urogen Pharma Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $43.99 (+1.38%). The 1-week path is $44.41 (+2.34%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Urogen Pharma Ltd Stock?
Urogen Pharma Ltd is a good buy right now due to its significant revenue growth, with Q2 2026 revenue reported at $72.5 million, a 73% increase sequentially, and a narrowing net loss of $14.4 million. The stock is currently priced at $43.62, well below the average analyst target of $60, suggesting a potential upside of 37.5%. However, the current RSI of 25.308 indicates the stock is oversold, which may present a buying opportunity despite recent volatility.
URGN stock price ended at $43.09 on Monday, after losing -1.22%
Urogen Pharma Ltd (URGN) last closed at $43.39, gaining +0.70%. These facts feed the 1-day and 1-week URGN price prediction above.
Analyst Consensus
Urogen Pharma Ltd (URGN): 3 buy, 1 hold, 0 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Urogen Pharma Ltd (URGN) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches URGN, ranked by similarity.
Seasonality analysis for URGN
Historically the probability of a positive September return for URGN is 52.38%. July offers the highest probability of a positive month at 96.97%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for URGN
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $4.52 | $5.53 | $6.70 | -87.25% |
| Oct 2026 | $5.07 | $5.18 | $6.50 | -88.06% |
| Nov 2026 | $3.51 | $4.63 | $5.05 | -89.34% |
| Dec 2026 | $5.50 | $5.85 | $7.21 | -86.52% |
In 2026, Urogen Pharma Ltd (URGN) is projected to range from $3.51 to $7.21.
Urogen Pharma Ltd 2026 monthly forecast
In Sep 2026, Urogen Pharma Ltd is projected to average $5.53, with a low of $4.52 and high of $6.70.
In Oct 2026, Urogen Pharma Ltd is projected to average $5.18, with a low of $5.07 and high of $6.50.
In Nov 2026, Urogen Pharma Ltd is projected to average $4.63, with a low of $3.51 and high of $5.05.
In Dec 2026, Urogen Pharma Ltd is projected to average $5.85, with a low of $5.50 and high of $7.21.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.